Selank in Horia — Anxiolytic Peptide Research Guide
Selank peptide guide for Horia. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
Selank isn't available on pharmacy shelves in Horia or virtually any local market — this is a specialist compound supplied via a dedicated online market. This matters because Selank quality varies dramatically across the market — from verified research-grade material to mislabeled or underdosed compounds — and the vendor is the entire quality system. Vendors worth sourcing from make readily available batch-matched Certificates of Analysis showing HPLC chromatograms, mass spec identity confirmation, endotoxin levels, and residual solvent results — all for the specific lot you are purchasing. The sections below cover what Horia researchers need to know about sourcing, verifying, and handling Selank for legitimate research applications.
How Selank Works — Mechanisms & Research
Selank belongs to a class of neuropeptides with documented activity in central nervous system models. Semax (ACTH4-7 Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone fragments, and has been shown in animal and some human research to increase brain-derived neurotrophic factor (BDNF) expression — a key signal for neuroplasticity, neuronal survival, and synaptic strengthening. Selank, a synthetic analogue of the endogenous peptide tuftsin, has been shown to modulate GABAergic transmission and influence enkephalinase activity, producing anxiolytic and nootropic effects in rodent models. For researchers in Horia studying cognitive biology and neuropeptide pharmacology, these compounds represent a productive area where mechanistic specificity is well-characterized.
How to Source Selank — Vendor Guide
Assessing Selank vendors requires starting from the COA: access the batch-specific certificate before purchasing, not after. A COA for Selank should include: HPLC purity percentage with the actual chromatogram data, mass spectrometry data confirming the correct molecular weight, endotoxin test results, and a residual solvent panel — all batch-matched. For Horia researchers evaluating unfamiliar vendors: a modest first purchase to test the product before scaling up your order is standard practice in the community. For Horia researchers making a first Selank purchase: work through this evaluation framework first, order conservatively at first, and confirm the COA batch number matches your received product before use.
Order Selank — ships to Horia
COA-verified · International tracking · Research grade
As a research compound, Selank has not been through the clinical trial process required for pharmaceutical approval — its safety profile is defined by animal study data and small-scale human observations. Lyophilised Selank should be placed in the freezer at −20°C straight away; repeated freeze-thaw cycles of reconstituted material should be avoided by aliquoting into single-use portions. Verify the endotoxin level in your Selank batch COA before use in any in-vivo protocol — look for results stated as EU/mg and confirm they fall within appropriate thresholds. The research literature on Selank should be reviewed carefully before designing any protocol — study approaches, dose levels, and measured endpoints vary significantly and not all findings translate directly.
Frequently Asked Questions
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
